Regencell Bioscience Holdings Limited logo

RGC Earnings — Regencell Bioscience Holdings Limited

NASDAQ

Updated

Price $6.95
Market Cap $3.4B
P/E -406.4
52W Range $4.51 – $69.00

When is RGC's next earnings date?

Regencell Bioscience Holdings Limited (RGC) has not announced its next earnings date yet. Its most recent earnings report was on Wednesday, October 28, 2026.

How did RGC do in its last earnings report?

In its most recent report on Oct 28, 2026, Regencell Bioscience Holdings Limited posted EPS of -$0.01. The stock's 1-day post-earnings move was -8.0%.

How much does RGC stock move after earnings?

Over the last 7 reports the stock moved an average of 7.7% (up or down) in the day after earnings.

About Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.

🤖 AI Earnings Analysis

EPS remained slightly negative at -$0.01, with revenue and estimates unavailable. Reported EPS growth is not enough to establish improvement from such a low base; evidence remains inconclusive.

AI-generated summary — powered by BigEarnings.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-10-28—-0.01———-8.04%——
2026-05-08H1 2026—-1.08—$0—-6.66%-2.39%-30.64%
2025-06-30H1 2025—-0.36—$0—-2.07%+5.92%-20.17%
2024-10-25FY 2024—-0.33—$0—+31.13%+73.94%+26.96%
2024-06-20H1 2024—-0.16—$0—-2.14%-9.01%-16.36%
2023-10-27FY 2023—-0.45—$0—-3.92%-13.92%-33.74%
2023-06-15H1 2023—-0.25—$0—+0.00%-1.76%-10.17%
2021-12-30—-0.01——————

Showing last 8 quarters.

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .